| 前收市價 | 2.5500 |
| 開市 | 2.8400 |
| 買盤 | 2.5900 |
| 賣出價 | 3.1000 |
| 拍板 | 45.00 |
| 到期日 | 2025-05-16 |
| 今日波幅 | 2.6300 - 2.8400 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 357 |
ZacksBristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
Bristol Myers' (BMY) Opdivo combination regimen receives the European Commission's approval for the first-line treatment of unresectable or metastatic urothelial carcinoma.
ZacksBristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ZacksProthena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
